OVERVIEW

Primary hyperparathyroidism affects 1% of the US population and is commonly under recognized and underdiagnosed. In this case based conference we will review the current recommendations for diagnostic evaluation and clinical decision making with a multidisciplinary team of experts. We will also cover the management strategies for hypoparathyroidism, a less common and important condition. Key takeaways during this live, 1-hour CME will be easily applied to your clinical practice.

LEARNING OBJECTIVES

1. Review the diagnostic evaluation of hyperparathyroidism
2. Describe an evidence based approach to decision making for surgical intervention vs surveillance
3. Illustrate key management strategies for patients with hypoparathyroidism

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. AMA PRA Category 1 Credits™ (1.00 hours).

For more information please visit the official event page.